Categories AlphaGraphs, Technology, U.S. Markets News
DocuSign Q1 earnings preview: Expect another quarter of strong customer additions
DocuSign (NASDAQ: DOCU) is scheduled to report first-quarter 2020 earnings results on June 6, Thursday, after the closing bell. The San Francisco-based firm is expected to report another strong quarter, as it continues to add partners and clients, thanks to the increased adoption of electronic signatures.
Wall Street projects Q1 earnings of 4 cents per share on revenues of $208.5 million, up 34% year-over-year. The revenue projection falls right in the middle of the company’s Q1 outlook range of $205-210 million. DocuSign management has also projected adjusted gross margin for this period in the range of 78-80%.
Over the past four quarters, the company has delivered consistent growth in customer additions and this is expected to continue in the first quarter. In the last-reported quarter, DocuSign said it added 23,000 customers, taking its global customer base to 477,000.
There has been a significant increase in market competition with the arrival of Adobe (NASDAQ: ADBE) and Dropbox (NASDAQ: DBX). However, DocuSign is yet to show a slowdown due to the entry of these new players.
According to Reports Monitor, the e-signature industry is set to grow at a yearly pace of 31% over the coming six years, hence there is plenty of headspace for growth.
DocuSign surprised Wall Street by reporting a profit in the fourth quarter of 2019, helped by a marked increase in revenues.
Revenues climbed 34% to $199.7 million in the fourth quarter, beating analysts’ estimate of $193.68 million. The top line was lifted by a 37% growth in subscription revenue.
The company reported adjusted earnings of $0.06 per share during the quarter, even as the market was expecting a breakeven.
DocuSign also raised its full-year outlook for total revenues to a range of $910-915 million, while billings are estimated to be $1.01-1.03 billion.
The stock, which started trading in April last year, has gained a modest 4.5% in the trailing 52 weeks, despite its relatively strong operational performance. During the year-to-date period, meanwhile, the stock is up 37%.
Analysts are quite bullish on the stock, which as a 12-month average price target of $11.18. This represents an 18% upside from the last closing price.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on